Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream
Clinical trial NCT05890703 · UNKNOWN
Trial details
- NCT number
- NCT05890703
- Sponsor
- Juerg Hafner
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2023-10-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.